Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE1

Conditions

DMD-Associated Dilated Cardiomyopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Kansas Medical Center, Kansas City, Kansas, United States
Contact: Study coordinator (Jillian Bruenn) · jfrick2@kumc.edu · 913-588-9720
Contact: Principal Investigator (Pradeep Mammen, MD)
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Heart Institute Neuromuscular Intake Line) · 513-803-3000
Contact: Principal Investigator (Chet Villa, MD)
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Kelsey Craig) · kelsey.craig@nationwidechildrens.org · 614-722-2715
Contact: Principal Investigator (Deipanjan Nandi, MD)

View source on ClinicalTrials.gov